Republic Finance’s Post

***MATCH ALERT*** What you may see when you see my son Hunter is an active, athletic, smart, funny, loving and handsome young man. Nearly 10 years ago, we found out his life would be burdened with the 24/7/365 job of doing what my pancreas and yours does without a thought. Producing insulin and administering just the right amount throughout the day. We don't think about how much insulin we need but Hunter needs to account for what he eats, how he exercises or performs on a field, stresses of tests, growth, puberty and sometimes it feels like even the phase of the moon. It is a grind. You see a healthy and active kid and we are grateful. We owe so much of that to the significant strides in research for how to manage Type 1 diabetes. Breakthrough technology including continuous glucose monitors and smarter insulin pump algorithms help to keep him safe, healthy and living his best life. These advancements wouldn’t be possible without Breakthrough T1D (formerly JDRF) and all of you that help make an impact in his life and in the lives of all those like Hunter with type 1 diabetes. There is no way to prevent T1D and, as of today, there is no cure. Breakthrough T1D is working hard to change that and that’s why our team is supporting the Kansas City Breakthrough T1D Walk again this year. Scientific advances are being turned into therapies that are changing the course of T1D and together we have the power to drive these therapies to market as quickly as we can. We hope you will join Hunter's Crew and invest in our efforts to help fund the best research that will produce cures and between now and that day, help those living with T1D live their best lives! Thank you! https://lnkd.in/gi_Nbg6a

Thank you to everyone that has signed on to this petition! We are getting closer to our goal. Please sign on and share with your networks: https://chng.it/cY4wWYwkzr Some fun facts: 1. North Carolina is the 2nd state to receive more doses of naloxone from Remedy Alliance for the People than any other state in the US. That is more than 100,000 doses per year.  (https://lnkd.in/ez3NZMQr) 2. There are roughly 50 syringe service programs in the state of NC. Many of These programs are under funded and receive free naloxone to support their communities. It is imperative that this medication be available for all. 3. Prioritizing community-based, grassroots syringe service programs is the BEST way to reach historically marginalized communities. People who use drugs and peer led programs offer an authentic and relatable approach. If these programs are not supported we will lose more loved ones to preventable overdose fatalities. As long as the drug war rages, people will continue to be deterred from the systems and structures that have oppressed and traumatized them and their loved ones for centuries. 

Evidence-based naloxone use is a common sense practice that SAVES LIVES. PWUD (people who use drugs) are people JUST AS deserving of compassion & respect as anyone else, and drug usage in and of itself IS NOT a morality issue. The vast majority of the public participates in *some* form of substance use - whether illicit or otherwise. Certain substances have just been regulated and thus have a safer supply. Change unfortunately often only happens one small step at a time, so let's start by holding our decision and policy makers accountable. Even if you aren't in NC, sign, because one step forward in one area often leads to waves of progress later!! "North Carolina harm reduction providers - which includes people who use drugs, people with living experience with substance use, health care providers, public health workers, policy makers, research professionals, and advocates for the health and safety of drug users - implore our state and counties to ensure that standard-dose naloxone formulations are available to community-based harm reduction groups and other statewide agencies offering syringe service programs. Specifically, we want continued intramuscular .4mg naloxone available as well as Harm Reduction Therapeutics’ 3mg intranasal naloxone RiVive as the primary options for distribution. At this time, and in alignment with other experts from across the US, we do not recommend the use of any high-dose (above 4mg) or long-acting overdose reversal agents in North Carolina by community groups, treatment providers, EMS and other first responders, or bystanders with access to naloxone. We also support the Call to Action published from the national Compassionate Overdose Response Summit. It is a fact that when it comes to overdose reversal more naloxone is not better naloxone. Companies are pushing higher-dose and longer-acting options that are going to put the most vulnerable populations at high-risk for harmful precipitated withdrawal. High-dose naloxone products like Kloxxado and other opioid antagonists such as Nalmefene may induce longer and more painful withdrawal that is not only unnecessary, but inhumane. We have had naloxone in its original form since the early 1970s, and newer formulations like RiVive 3mg intranasal naloxone are just as effective at knocking opioids off the receptors and, with rescue breathing occurring in tandem, can restore life. By signing this petition, we the people and organizations strongly encourage our state and local leadership and policy makers to give all responders and communities these safe, compassionate choices that sustain and support the people we love." https://chng.it/cY4wWYwkzr

You have every right to aim for a standard A1c and a typical C-Peptide. 

Next on our list is 𝐒𝐞𝐥𝐞𝐜𝐭𝐢𝐯𝐞 𝐅𝐞𝐭𝐚𝐥 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐬𝐭𝐫𝐢𝐜𝐭𝐢𝐨𝐧 (𝐒𝐅𝐆𝐑), 𝐚𝐥𝐬𝐨 𝐤𝐧𝐨𝐰 𝐚𝐬 𝐒𝐈𝐔𝐆𝐑. This is characterized by a size discordances of more than 20% between the twins, and one baby being below the 10th percentile. The Gratacós classification system is widely used, but alternatives have been suggested. SFGR generally happens when there is unequal sharing of the placenta, and when the cord insertion points are close to the edge, or on the edge of the placenta. SFGR is classified based on the flow in the umbilical cord, being absent, reversed, normal, or intermittent. There are options for treatment, but the emerging consensus is to watch and see what happens, with close monitoring always. There are more short term issues for the bigger twin, but the smaller twin has more long term complications. The LEMON Study helped us learn more about SFGR. (more: https://bit.ly/3wzhVqk ) What's interesting is that SFGR sits on it's own little branch of the complications umbrella - TTTS, TAPS and TRAP are caused by unbalanced intertwin blood transfusion, where SFGR is caused by inadequate sharing of the placenta! Learn more about the differences between TTTS, TAPS and SFGR on our website here: https://bit.ly/3E9rVFv #rarediseaseday #raretwins #ttts #taps #sfgr #trap #tapssupport

🩺 Hep C + Vasculitis? Think Mixed Cryoglobulinemia Syndrome! 💡 #step2ck Key clues: Hepatitis C, Raynaud's, and Melzer's triad (peripheral neuropathy, palpable purpura, weakness/arthralgias). High-yield for Step 2—don’t miss it! 🔑 Check the link in my bio and schedule a FREE call if you're ready to elevate your med school performance 📈🏆 #USMLE #Step1 #usmleprep #STEP2 #HighYield #MedSchoolTips #HepatitisC #Vasculitis

Now that Wegovy has been approved to help reduce the risk of cardiovascular events, you may be wondering what other indications are in the GLP-1 pipeline. Take a deep dive with our new article: https://cvs.co/3M394Sf #GLP1s #WeightManagement #Pipeline

Comment "22gtransfusion" if you want to see the whole conversation If you only have one well-working 22g IV catheter and need to transfuse 2 units of blood, there are strategies to ensure a smooth transfusion: 1. Sequential Transfusion: Transfuse one unit at a time, monitoring closely for reactions. 2. Coordinate with blood bank to split the unit bags with less volume to transfuse within the 4hr time frame. 3. Blood Warmer: Slightly warm the blood to improve flow. 4. Slow and Steady Approach: Plan for an extended time frame for the transfusion. 5. Optimize IV Site: Regularly check the IV site for patency. 6. Additional IV Access: Consider establishing another IV access site with a larger gauge catheter.

Did you know that people who have a first-degree family member (sibling, parent, child) with type 1 diabetes (T1D) are at an increased risk (15x) for developing the condition? And about 85% of T1D diagnoses occur in people with no known family connection at all. Join Breakthrough T1D Upstate New York the first week of November at a T1D Early Detection Info Fair to get more information on screening for T1D, who is eligible, and why it's so important. https://lnkd.in/eMD5BzfU

Learn more about what happens to red blood cells during storage. #StoredRBCs https://lnkd.in/d69r_9NW #hemanext #StoredRedBloodCells